Acute chest pain (ACP) is a common symptom that can signify a broad spectrum of conditions, ranging from benign to life-threatening. Differentiating between these possibilities is a complex task that requires a comprehensive and systematic approach.
The initial assessment of a patient presenting with ACP should include a detailed history, physical examination, and basic diagnostic tests. It is essential to identify risk factors for coronary artery disease (CAD), such as hypertension, diabetes, smoking, and family history. The nature, duration, and radiation of the pain can provide valuable clues to its etiology.
The differential diagnosis of ACP is vast. It includes cardiac causes like acute coronary syndrome (ACS) and pericarditis, gastrointestinal causes like gastroesophageal reflux disease (GERD) and peptic ulcer disease, respiratory causes like pulmonary embolism and pneumothorax, and musculoskeletal causes like costochondritis. Psychological causes, such as panic disorder, should also be considered.
Diagnostic testing for ACP should be guided by the suspected diagnosis. Electrocardiogram (ECG) and cardiac biomarkers are essential for diagnosing ACS. Chest X-ray can help identify pneumothorax and pneumonia. Computed tomography (CT) angiography can rule out pulmonary embolism. Endoscopy and esophageal pH monitoring can help diagnose GERD.
The management of ACP depends on the underlying cause. ACS requires immediate revascularization. GERD can be managed with proton pump inhibitors. Pulmonary embolism requires anticoagulation. Psychological causes may require cognitive-behavioral therapy and pharmacotherapy.
Acute chest pain is a challenging symptom that requires a comprehensive approach. Prompt identification and management of the underlying cause can significantly improve patient outcomes. Continuous professional development and staying abreast with the latest evidence can help healthcare professionals in this endeavor.
1.
Combo Therapy Boosts Early CML Response but Not Long Term
2.
PNH With Extravascular Hemolysis Approves Factor D Inhibitor.
3.
In a long-term comparison with adjuvant RT, salvage radiotherapy after prostateectomy is the most successful treatment.
4.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
5.
Classifying childhood brain cancers by immune response may improve diagnostics and treatments
1.
Precision Oncology: Integrating Genomics and Data to Shape Cancer Care’s Future
2.
Decoding Hamartomas: Understanding Their Causes and Symptoms
3.
Understanding the Silent Threat: Unveiling Prostate Cancer Symptoms
4.
Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era
5.
Breaking Barriers: Innovative Approaches in Brain Tumor Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
3.
Efficient Management of First line ALK-rearranged NSCLC
4.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation